Formulation and Evaluation of Taste Masked Mouth Dissolving Tablets of Levocetirizine Hydrochloride

Authors

  • Himansu Chopra Faculty of Pharmacy, GRD (PG) IMT, 214-Rajpur Road, Dehradun (U.K.), India.
  • Vijay Sharma Faculty of Pharmacy, P.R.C., PRIST University, Thanjavur (T.N.), India.
Abstract:

   Aim of this research work was to develop mouth dissolving tablet that disintegrates rapidly in mouth by using tasteless complex of Levocetirizine and Tulsion-335. Effect of different parameters such as swelling time, resin activation, drug resin ratio as well as stirring time was optimized by taste and percentage drug loading. Formulated DRC (Drug Resin Complex) was characterized by infrared spectroscopy, thermal analysis and X-ray diffraction pattern. Tablets were formulated by wet granulation with PVP as binder, Sodium Starch Glycolate (SSG) and Crospovidone as super disintegrants. In these batches optimum hardness was achieved but disintegration time was found to be very high as ≥ 70 second, so further trials were planned by using different superdisintegrants such as Croscarmellose sodium, Sodium Starch Glycolate (SSG) as well as Crospovidone by wet granulation method. Tablets formulated with 7.5% crospovidone showed comparatively low disintegration time (25 sec), wetting time (20 sec) and friability (0.60 %) than the other batches. In present study we optimized the conditions required for maximum drug loading of Levocetirizine with Tulsion-335. Among different superdisintergants, crospovidone was found suitable with drug-resin complex to get the low disintegration time, wetting time and friability of tablets.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine

The purpose of this research was to develop mouth dissolve tablets of cinnarizine by effervescent, superdisintegrant addition and sublimation methods. All the three formulations were evaluated for disintegration time, hardness and friability, among these superdisintegrant addition method showed lowest disintegration time; hence it was selected for further studies. Further nine batches (B1-B9) w...

full text

Mouth Dissolving Tablets of Losartan Potassium: Formulation and Evaluation

Losartan potassium is an angiotention receptor antagonist, used in the management of hypertension. The objective of the proposed research work is to prepare and evaluate the mouth dissolving/disintegrating tablets (MDTs) of losartan Potassium, which avoid the first-pass metabolism, improved the dissolution rate and enhance the bioavailability. Mouth dissolving tablets (MDTs) were prepared by di...

full text

Formulation and Evaluation of Taste Masked Dispersible Tablets of Zidovudine

Zidovudine is an antiretroviral drug commonly used in the treatment HIV infection. But it is very bitter in taste and sparingly soluble in water. Thus the purpose of this investigation was to formulate and evaluate taste masked dispersible tablets of zidovudine. Dispersible tablets of zidovudine were prepared using crosscarmellose sodium (Ac-di-sol) as disintegrant. Surelease clear (E-7-19010) ...

full text

Optimization, Formulation and In-Vitro Evaluation of Mouth Dissolving Tablets of Levocetrizine Hydrochloride for the Treatment of Allergic Rhinitis

New era is an era of novel drug delivery systems. Pediatric, Geriatric and bed ridden patients have difficulties in swallowing tablets. The purpose of the present study was to develop and characterize mouth dissolving tablets of Levocetrizine Hydrochloride by using direct compression technique. Formulations were designed by factorial design technique. Sodium starch glycolate, Crospovidone and C...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 11  issue 2

pages  457- 463

publication date 2011-11-27

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023